Cross Country Healthcare WKN: 550897 ISIN: US2274831047 Kürzel: XXY Forum: Aktien User: Summer.76

https://www.businesswire.com/news/home/20231031339688/en/Cross-Country-Healthcare-Announces-Third-Quarter-2023-Financial-Results

https://www.nasdaq.com/articles/cross-country-ccrn-reports-q4-earnings:-what-key-metrics-have-to-say

https://ir.crosscountryhealthcare.com/news-releases/news-release-details/cross-country-healthcare-announces-first-quarter-2023-financial

https://www.rttnews.com/3345812/cross-country-healthcare-inc-q4-profit-decreases-but-beats-estimates.aspx?type=ern

Cross Country Healthcare Announces Fourth Quarter and Full Year 2022 Financial Results https://www.businesswire.com/news/home/20230221005783/en/Cross-Country-Healthcare-Announces-Fourth-Quarter-and-Full-Year-2022-Financial-Results

Cross Country Healthcare Completes Acquisition of Hireup Leadership Inc. https://www.businesswire.com/news/home/20221208005725/en/Cross-Country-Healthcare-Completes-Acquisition-of-Hireup-Leadership-Inc.

https://www.finanzen.at/nachrichten/aktien/cross-country-healthcare-stellte-das-zahlenwerk-zum-vergangenen-quartal-vor-1031867778

Cross Country Healthcare Non-GAAP EPS of $1.07 beats by $0.12, revenue of $636.09M beats by $17.62M https://seekingalpha.com/news/3900372-cross-country-healthcare-non-gaap-eps-of-1_07-beats-0_12-revenue-of-636_09m-beats-17_62m • Cross Country Healthcare press release (NASDAQ:CCRN): Q3 Non-GAAP EPS of $1.07 beats by $0.12. • Revenue of $636.09M (+69.7% Y/Y) beats by $17.62M.

Cross Country Healthcare Announces Third Quarter 2022 Financial Results https://www.businesswire.com/news/home/20221101005972/en/Cross-Country-Healthcare-Announces-Third-Quarter-2022-Financial-Results

https://finance.yahoo.com/news/cross-country-ccrn-incredible-growth-164504575.html

Paring My Cross Country Healthcare Gains https://seekingalpha.com/article/4543810-paring-my-cross-country-healthcare-gains Summary • The most recent financial performance has been extremely good in my view. Although indebtedness has climbed massively, there's little risk in the capital structure in my view. • The issue for me is the stock price. It's neither cheap nor expensive at the moment, and so, in the interests of preserving capital, I'm paring my gains. • If you're just joining us, I would recommend building a position over the next six months, mindful of the fact that shares are near all time high prices. ...

Cross Country Healthcare (NASDAQ:CCRN) Updates Q3 2022 Earnings Guidance https://www.marketbeat.com/instant-alerts/nasdaq-ccrn-earnings-guidance-2022-09-2/ ...updated its third quarter 2022 earnings guidance on Wednesday. The company provided earnings per share guidance of $0.90-$1.00 for the period, compared to the consensus earnings per share estimate of $0.91. The company issued revenue guidance of $615.00 million-$625.00 million, compared to the consensus revenue estimate of $610.51 million. Cross Country Healthcare also updated its FY 2023 guidance to EPS. ...

https://apnews.com/article/health-united-states-2aafde3d67ee4410966a66489aa9e35e

"2022-08-16 | NDAQ:CCRN | Press Release | Cross Country Healthcare Inc." https://stockhouse.com/news/press-releases/2022/08/16/cross-country-healthcare-announces-authorization-of-a-new-100-million-stock

Cross Country Healthcare Announces Second Quarter 2022 Financial Results https://stockhouse.com/news/press-releases/2022/08/03/cross-country-healthcare-announces-second-quarter-2022-financial-results